BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27060232)

  • 1. Endothelial nitric oxide synthase tagSNPs influence the effects of enalapril in essential hypertension.
    Oliveira-Paula GH; Lacchini R; Luizon MR; Fontana V; Silva PS; Biagi C; Tanus-Santos JE
    Nitric Oxide; 2016 May; 55-56():62-9. PubMed ID: 27060232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril.
    Oliveira-Paula GH; Luizon MR; Lacchini R; Fontana V; Silva PS; Biagi C; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):284-291. PubMed ID: 27696692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents.
    de Miranda JA; Lacchini R; Belo VA; Lanna CM; Sertorio JT; Luizon MR; Tanus-Santos JE
    J Hum Hypertens; 2015 Feb; 29(2):109-14. PubMed ID: 24943287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril.
    Silva PS; Fontana V; Luizon MR; Lacchini R; Silva WA; Biagi C; Tanus-Santos JE
    Eur J Clin Pharmacol; 2013 Feb; 69(2):167-77. PubMed ID: 22706620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril.
    Oliveira-Paula GH; Lacchini R; Fontana V; Silva PS; Biagi C; Tanus-Santos JE
    Eur J Clin Pharmacol; 2015 Aug; 71(8):949-57. PubMed ID: 26002049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study.
    Gamil S; Erdmann J; Abdalrahman IB; Mohamed AO
    BMC Med Genet; 2017 Nov; 18(1):128. PubMed ID: 29132319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol.
    Oliveira-Paula GH; Lacchini R; Pinheiro LC; Ferreira GC; Luizon MR; Garcia WNP; Garcia LV; Tanus-Santos JE
    Nitric Oxide; 2018 May; 75():77-84. PubMed ID: 29496565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.
    Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX
    IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers.
    Silva PS; Fontana V; Palei ACT; Sertório JTC; Biagi C; Tanus-Santos JE
    Eur J Clin Pharmacol; 2011 Apr; 67(4):365-370. PubMed ID: 21305271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study.
    Conen D; Glynn RJ; Buring JE; Ridker PM; Zee RY
    J Hypertens; 2008 Sep; 26(9):1780-6. PubMed ID: 18698212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy.
    Aggarwal PK; Jain V; Jha V
    Hypertens Res; 2010 May; 33(5):473-7. PubMed ID: 20186148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the endothelial nitric oxide synthase gene on conventional and ambulatory blood pressure: sib-pair analysis and haplotype study.
    Persu A; Vinck WJ; El Khattabi O; Janssen RG; Paulussen AD; Devuyst O; Vlietinck R; Fagard RH
    J Hypertens; 2005 Apr; 23(4):759-65. PubMed ID: 15775780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of
    Cunha WR; Agostini LC; Dos Moreira WM; M Teixeira LF; Vital WC; da Silva GN; Silva NN; Luizon MR; Oliveira-Paula GH; Lima AA; Belo VA
    Pharmacogenomics; 2023 Apr; 24(5):269-281. PubMed ID: 37014323
    [No Abstract]   [Full Text] [Related]  

  • 15. Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension.
    Nejatizadeh A; Kumar R; Stobdan T; Goyal AK; Sikdar S; Gupta M; Javed S; Pasha MA
    Free Radic Biol Med; 2008 Jun; 44(11):1912-8. PubMed ID: 18325347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endothelial nitric oxide synthase tagSNPs haplotypes on nitrite levels in black subjects.
    Metzger IF; Luizon MR; Lacchini R; Ishizawa MH; Tanus-Santos JE
    Nitric Oxide; 2013 Jan; 28():33-8. PubMed ID: 23069892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol.
    Oliveira-Paula GH; Pereira DA; Pinheiro LC; Ferreira GC; Paula-Garcia WN; Garcia LV; Lacchini R; Luizon MR; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2022 Feb; 130(2):277-287. PubMed ID: 34825477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension.
    Fontana V; Silva PS; Izidoro-Toledo TC; Biagi C; Oliveira EB; Gerlach RF; Tanus-Santos JE
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):511-9. PubMed ID: 23085896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production.
    Oliveira-Paula GH; Pinheiro LC; Ferreira GC; Garcia WNP; Lacchini R; Garcia LV; Tanus-Santos JE
    Free Radic Biol Med; 2018 Feb; 115():10-17. PubMed ID: 29138017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.